By Ian Walker Pfizer, the pharmaceutical giant, has revealed plans to discontinue its Pharmaceutical Sciences Small Molecule operations at its location in Sandwich, Kent, England. This decision will unfortunately result in the loss of approximately 500 jobs. However, it is important to note that Pfizer's other functions at the Sandwich site will remain operational, reassuring … [Read more...] about Pfizer to Cease Operations at Site in Sandwich, England
Pfizer
FDA Addresses Concerns about Tornado’s Impact on Pfizer Plant
The Food and Drug Administration (FDA) has moved swiftly to alleviate concerns over potential drug shortages following the tornado strike on a Pfizer plant in North Carolina. Assuring the public, the FDA stated that there are currently ample supplies of drugs in hospitals and the distribution system to prevent a crisis. Contrary to initial reports that the plant supplied 25% of … [Read more...] about FDA Addresses Concerns about Tornado’s Impact on Pfizer Plant
Caribou Biosciences Receives $25 Million Investment from Pfizer
Shares of Caribou Biosciences, a clinical-stage genome-editing biopharmaceutical company, saw a significant surge in premarket trading following news of a $25 million equity investment from drug giant Pfizer. This investment has been made at a healthy premium and has propelled Caribou's shares up by 36% to $5.56 during premarket trading. Pfizer purchased approximately 4.69 … [Read more...] about Caribou Biosciences Receives $25 Million Investment from Pfizer
Pfizer Offers South Africa Discounted COVID-19 Vaccines
Pfizer and BioNTech SE offered to supply South Africa with COVID-19 vaccine at a discounted $10 a dose, according to Bloomberg. The price was worked out according to South Africa’s classification as a middle-income country. The price offered to South Africa is half of what the drugmakers are charging in the U.S. despite the president’s office terming it prohibitive.The … [Read more...] about Pfizer Offers South Africa Discounted COVID-19 Vaccines
